SCHEMBL7811025

SCHEMBL7811025

Cn1[c]nc2ccc(C(C)(C)C)cc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN10A Q9Y5Y9 5/20 0.35
KCNH2 Q12809 2/20 0.35
ALDH1A1 P00352 4/20 0.34
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
HTR1D P28221 1/20 0.33
TRPV1 Q8NER1 1/20 0.32
LRRK2 Q5S007 1/20 0.32
MAPT P10636 2/20 0.32
PKM P14618 2/20 0.32
MEN1 O00255 1/20 0.32
GAA P10253 1/20 0.32
RECQL P46063 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7815089 0.86 HTR1D (0.36) SCN10AKCNH2ALDH1A1HPGDALOX15
SCHEMBL7810834 0.84 KIF11 (0.42) ALDH1A1PKM
SCHEMBL2157981 0.76 CYP11B1 (0.39) ALDH1A1MEN1KMT2A
SCHEMBL4894034 0.76 TLR8 (0.37) ALDH1A1TDP1MAPTMEN1GAA
SCHEMBL7814927 0.75 HASPIN (0.35)
SCHEMBL7814408 0.74 NPM1 (0.35) ALDH1A1ALOX15MAPTMEN1KMT2A
SCHEMBL5982654 0.74 PTPN1 (0.42) ALDH1A1HPGDHSD17B10TDP1MAPT
SCHEMBL7815237 0.74 ESR1 (0.37) ALDH1A1HPGDHSD17B10HTR1DMAPT
SCHEMBL7818322 0.71 MAP3K14 (0.38) ALDH1A1HPGDALOX15HSD17B10MAPT
SCHEMBL3651143 0.70 PKM (0.50) ALDH1A1HSD17B10HTR1DPKMMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0745600-B1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-10-24 EP disclosed
US-5886014-A TREATMENT AND/OR PROPHYLAXIS OF A VARIETY OF DISORDERS, INCLUDING HYPERLIPEMIA, HYPERGLYCEMIA, OBESITY, IMPAIRED GLUCOSE TOLERANCE (IGT), INSULIN RESISTANCE AND DIABETIC COMPLICATIONS SANKYO COMPANY, LIMITED (JP) 1999-03-23 US disclosed
EP-0745600-A1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-12-04 EP disclosed